These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 28821581

  • 1. Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia.
    Sun Y, Tang G, Hu Z, Thakral B, Miranda RN, Medeiros LJ, Wang SA.
    J Clin Pathol; 2018 Apr; 71(4):309-315. PubMed ID: 28821581
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
    Hu Z, Medeiros LJ, Fang L, Sun Y, Tang Z, Tang G, Sun T, Quesada AE, Hu S, Wang SA, Pei L, Lu X.
    Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
    [Abstract] [Full Text] [Related]

  • 3. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
    Hsi AC, Robirds DH, Luo J, Kreisel FH, Frater JL, Nguyen TT.
    Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
    [Abstract] [Full Text] [Related]

  • 4. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.
    López C, Bergmann AK, Paul U, Murga Penas EM, Nagel I, Betts MJ, Johansson P, Ritgen M, Baumann T, Aymerich M, Jayne S, Russell RB, Campo E, Dyer MJ, Dürig J, Siebert R.
    Br J Haematol; 2016 Apr; 173(2):265-73. PubMed ID: 26917488
    [Abstract] [Full Text] [Related]

  • 5. TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.
    Yokohama A, Saitoh A, Nakahashi H, Mitsui T, Koiso H, Kim Y, Uchiumi H, Saitoh T, Handa H, Jimbo T, Murayama K, Sakura T, Murakami H, Karasawa M, Nojima Y, Tsukamoto N.
    Int J Hematol; 2012 Jan; 95(1):77-85. PubMed ID: 22189846
    [Abstract] [Full Text] [Related]

  • 6. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
    Sun S, Fang W.
    Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
    [Abstract] [Full Text] [Related]

  • 7. T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
    Hu Z, Medeiros LJ, Xu M, Yuan J, Peker D, Shao L, Tang Z, Mai B, Thakral B, Rios A, Hu S, Wang W.
    Am J Clin Pathol; 2023 Apr 04; 159(4):325-336. PubMed ID: 36883805
    [Abstract] [Full Text] [Related]

  • 8. Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia.
    Patil P, Cieslak A, Bernhart SH, Toprak UH, Wagener R, López C, Wiehle L, Bens S, Altmüller J, Franitza M, Scholz I, Jayne S, Ahearne MJ, Scheffold A, Jebaraj BMC, Schneider C, Costa D, Braun T, Schrader A, Campo E, Dyer MJS, Nürnberg P, Dürig J, Johansson P, Böttcher S, Schlesner M, Herling M, Stilgenbauer S, Macintyre E, Siebert R.
    Genes Chromosomes Cancer; 2020 Apr 04; 59(4):261-267. PubMed ID: 31677197
    [Abstract] [Full Text] [Related]

  • 9. Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization.
    Maljaei SH, Brito-Babapulle V, Hiorns LR, Catovsky D.
    Cancer Genet Cytogenet; 1998 Jun 04; 103(2):110-6. PubMed ID: 9614908
    [Abstract] [Full Text] [Related]

  • 10. IGH gene involvement in two cases of acute lymphoblastic leukemia with t(14;14)(q11;q32) identified by sequential R-banding and fluorescence in situ hybridization.
    Liu S, Bo L, Liu X, Li C, Qin S, Wang J.
    Cancer Genet Cytogenet; 2004 Jul 15; 152(2):141-5. PubMed ID: 15262434
    [Abstract] [Full Text] [Related]

  • 11. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
    Chen X, Cherian S.
    Am J Clin Pathol; 2013 Nov 15; 140(5):727-35. PubMed ID: 24124154
    [Abstract] [Full Text] [Related]

  • 12. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
    Hu Z, Li S, Medeiros LJ, Sun T.
    Hum Pathol; 2017 Jul 15; 65():175-179. PubMed ID: 28232160
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. T cell prolymphocytic leukemia with new chromosome rearrangements.
    Zver S, Kokalj Vokac N, Zagradisnik B, Erjavec A, Zagorac A, Zupan IP, Cernelc P.
    Acta Haematol; 2004 Jul 15; 111(3):168-70. PubMed ID: 15034240
    [Abstract] [Full Text] [Related]

  • 15. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire.
    Garand R, Goasguen J, Brizard A, Buisine J, Charpentier A, Claisse JF, Duchayne E, Lagrange M, Segonds C, Troussard X, Flandrin G.
    Br J Haematol; 1998 Nov 15; 103(2):488-94. PubMed ID: 9827924
    [Abstract] [Full Text] [Related]

  • 16. Translocations t(X;14)(q28;q11) and t(Y;14)(q12;q11) in T-cell prolymphocytic leukemia.
    de Oliveira FM, Tone LG, Simões BP, Rego EM, Marinato AF, Jácomo RH, Falcão RP.
    Int J Lab Hematol; 2009 Aug 15; 31(4):453-6. PubMed ID: 18294235
    [Abstract] [Full Text] [Related]

  • 17. Relationship of T leukaemias with cerebriform nuclei to T-prolymphocytic leukaemia: a cytogenetic analysis with in situ hybridization.
    Brito-Babapulle V, Maljaie SH, Matutes E, Hedges M, Yuille M, Catovsky D.
    Br J Haematol; 1997 Mar 15; 96(4):724-32. PubMed ID: 9074412
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.
    Herling M, Patel KA, Teitell MA, Konopleva M, Ravandi F, Kobayashi R, Jones D.
    Blood; 2008 Jan 01; 111(1):328-37. PubMed ID: 17890451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.